PO
Therapeutic Areas
Anteris Technologies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| DurAVR™ THV | Severe Aortic Stenosis | Pivotal |
| DurAVR™ THV (Small Annuli) | Severe Aortic Stenosis in Small Aortic Annuli | Early Feasibility / Post-Market |
Leadership Team at Anteris Technologies
WP
Wayne Paterson
Vice Chairman and Chief Executive Officer
DC
Dr. Christopher Meduri
Chief Medical Officer
DM
Dr. Michael Reardon
Professor of Cardiothoracic Surgery (KOL)
DR
Dr. Rebecca T. Hahn
Director of Interventional Echocardiography (KOL)
DJ
Dr. Jeffrey Popma
Presenting Investigator (KOL)
PN
Prof. Nicolas Van Mieghem
Key Opinion Leader / Investigator
DR
Dr. Rishi Puri
Principal Investigator (KOL)